This first installment will lay the foundation for understanding how CAR T works. Future installments will focus on CAR T applications and recent innovations which further the field.

This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

The Central Dogma of Biology. Biological information flows along a one-way street, or does it? A new paper questions the validity of long-held tennents.

A group of researchers at Qatar Foundation have reported the first and largest genetic association study in the Middle East, that has been published online in Nature Communications